Serum Institute of India’s vaccine to treat cervical cancer gets DCGI’s nod, to launch later this year
Image Credit: PTI
Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year. DCGI on Tuesday granted market authorisation to Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer.